Investigating how different starch types affect glucose metabolism in overweight adults
Official title: Personalized Metabolic Responses to Rapid, Slow and Resistant Starch (PerStarch)
Run by Chalmers University of Technology · NCT06897241 · Data updated 2026-11-12
This study is testing how different types of starch affect blood sugar levels in overweight adults with different gut bacteria and gene variations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 75 Years |
| Sex | All |
| Enrollment | 96 (estimated) |
| Sponsor | Chalmers University of Technology Academic / other |
| Locations | 1 site (Gothenburg, Västra Götaland County) |
| Status | Recruiting |
| Started | April 8, 2025 |
| Main results expected | May 1, 2026 |
| Study ends | May 1, 2026 |
| Registry record updated | May 16, 2025 |
| Trial ID | NCT06897241 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men and post-menopausal women aged 30-75 with a BMI between 27-40 kg/m2.
✕Probably not a fit
Patients with diabetes, recent cardiovascular events, or significant gastrointestinal conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the metabolic responses of individuals with varying gut microbiota and AMY1 gene copy number to three types of starch: resistant, slow digestible, and rapid digestible. Over a 12-week period, participants will undergo a randomized, cross-over feeding intervention, where they will consume each type of starch for 14 days, separated by wash-out periods. Blood, saliva, and fecal samples will be collected to analyze glucose metabolism and gut microbiota composition. Participants will also complete questionnaires regarding their dietary intake, lifestyle, and health-related quality of life.
Why it matters
Potential benefit: If successful, this study could lead to personalized dietary recommendations for improving glucose metabolism in overweight and obese individuals.
How similar studies have gone: While there is ongoing research into personalized nutrition based on gut microbiota, this specific approach to starch types and glucose metabolism is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and post-menopausal women * Age 30-75 years * BMI 27-40 kg/m2 * Waist circumference \> 102/88 cm for men/women * Weight stable during previous 3 months (± 3 kg) * Willingness to consume the intervention diets * Ability to deal with the monitoring devices * Medications stable for the previous 14 days * Signed informed consent Exclusion Criteria: * Cardiovascular events (myocardial infarction or stroke) during the previous 6 months * Diagnosis of diabetes (any type) or use of any drug who can interfere with glucose homeostasis (i.e., metformin, incretin analogues, SGLT-2 inhibitors) * History of stomach or gastrointestinal conditions (inflammatory bowel disease, Crohn's disease, malabsorption, etc.) * Colostomy, bowel resection, bariatric surgery or other major gastrointestinal surgery * Renal or liver failure (creatinine \<1.7 mg/dl and alanine aminotransferase/aspartate aminotransferase \< 2 times than normal values, respectively) * Anemia (hemoglobin below the age and sex specific normal reference ranges at screening) * Blood donation (or participation in a clinical study with blood sampling) within 30 days prior to inclusion * Having been treated with antibiotics within the past 3 months or planning to undergo treatment during the study period. * Habitual use of probiotic/prebiotic supplements or foods enriched in probiotics * Celiac disease * Vegan/vegetarian diet (or a diet incompatible with protocol diets) * Intense physical activity regimen (\> 7 h/week of moderate intensity or \> 3 h/week of high intensity) * History of drug or alcohol abuse * Not able to understand written and spoken Swedish * Any other reason for lack of suitability for participation in the trial, as judged by the principal investor or co-principal investigator
Where it's running
-
Clinical Trial Center, Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, Sweden Recruiting
Study contacts
- Principal investigator: Rikard Landberg — Chalmers University of Technology
- Study coordinator: Anna Hjort
- Email: anna.hjort@chalmers.se
- Phone: 0046317722848
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise plus a thermogenic nutritional supplement to improve body composition and metabolic health in middle-aged adults with high body fat
This 12-week program will test whether adding a thermogenic, appetite‑modulating supplement to a multicomponent exercise plan helps 50–65-year-olds who are overweight with high body fat improve body composition and metabolic markers.
-
A dietary and behavioral intervention to improve health and sustainability
This study is testing a new lifestyle program that combines diet tips and support to see if it can help people improve their health and the environment better than regular diet advice alone.
-
Personalized dietary advice based on metabolic responses
This study is testing whether personalized diet plans based on how your body reacts to food can improve heart and metabolic health better than a standard healthy diet for people aged 40 to 70 who are slightly overweight.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.